Avricore Health Inc. (V:AVCR)

Business Focus: Pharmaceuticals (NEC)

Get the company report for the most recent outlook updated daily

Apr 04, 2024 07:30 am ET

HealthTab™ Signs Agreement for More Rexall® Pharmacy Locations

Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) is pleased to announce further expansion of HealthTab™ with Rexall Pharmacy Group ULC (“Rexall”). The Companies have been working closely to develop the best patient...

Nov 30, 2023 12:58 pm ET

Avricore Health Corporate Update – Company Demonstrates Strong Growth

AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) reports on its third quarter results which demonstrate significant growth in pharmacy locations offering HealthTab driving strong revenue growth and operational cashflow positivity. With...

Sep 15, 2023 12:53 pm ET

HealthTab™ Supports Patient Testing in the First Rexall® Pharmacy Walk-In Clinic

Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) is expanding its innovative point-of-care chronic and infectious disease screening and health-data management platform, HealthTab™, further into the Canadian...

Aug 30, 2023 08:00 am ET

Avricore Health Corporate Update – Mid-Year Review Demonstrates Company on Right Track

AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) continues to achieve significant growth, new partnerships and developing new markets while surpassing margin targets. Now, as the Company looks back at the first half of the year, it...

Aug 08, 2023 11:54 am ET

HealthTab™ Signs Reseller Agreement With Abbott to Support UK Expansion

Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) is pleased to announce the signing of a reseller agreement between HealthTab™ Inc. and Abbott Rapid Dx UK & Ireland. This agreement provides a foundation for...

Aug 03, 2023 08:30 am ET

Avricore’s HealthTab Selected for Feasibility Study for Testing in Community Pharmacies in United Kingdom

Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) is pleased that HealthTab, the Company’s leading pharmacy-based platform for testing and health data management, has been selected by a collaborative involving the...

Jul 19, 2023 08:00 am ET

HealthTab™ to Integrate CONTOUR®NEXT Family of Blood Glucose Meters to Offer Deeper Diabetes Patient Insights

Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) is pleased to announce its agreement with Ascensia Diabetes Care, a global diabetes care company, to integrate their blood glucose monitoring (BGM) systems, marketed...

Jun 21, 2023 06:38 pm ET

Avricore Health Hosts 2023 Annual General Meeting and Welcomes New Board Members

AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) held its annual general meeting to elect directors, appoint its auditor and accept a new stock option plan to support the company’s continued growth. “It’s been another amazing year...

May 15, 2023 02:06 pm ET

Avricore Grants Options

AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) today announces that the Company’s board of directors has approved the granting of stock options (the “Options”) exercisable for a total of 1,625,000 common shares to its directors,...

May 02, 2023 07:30 am ET

Avricore Health Corporate Updates on Audited Results for 2022

AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) today is pleased to announce its audited final results for 2022. The Company achieved record revenues of over $1.75 million while it also continues to narrow the gap to...

Mar 23, 2023 10:46 am ET

Avricore Health’s HealthTab™ Passes 530 Locations, Adds Virus Detection

AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) continues to grow the HealthTab™ network of pharmacy locations, reaching 532 locations. In 100 of these locations, the Company will be deploying Abbott’s ID Now™, either in combination...

Feb 21, 2023 10:00 am ET

Avricore Health Makes the Grade on 2023 TSX Venture 50

AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) has been honoured by being named as one of the 2023 Venture 50, the TSX Venture Exchange’s list of top performing companies. “To make the Venture 50 feels great and the whole team is...

Feb 01, 2023 08:00 am ET

Avricore Health Corporate Update – Earnings Advisory 2022 and 2023 Objectives

AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) is entering the second year of a multi-year growth plan to bring HealthTab, its turnkey solution for point of care testing and data management, to more pharmacies across Canada and the...

Nov 29, 2022 11:08 am ET

Avricore Health Reports Third-Quarter 2022 Results

AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) today released its Q3 results which demonstrate significant revenue growth, indicating it can scale sustainably and deliver on its long-term objectives. The Company’s objective to...

Oct 21, 2022 09:00 am ET

Avricore to Present at Emerging Growth Conference on Oct. 26, 2022

AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) is excited to present at the Emerging Growth Conference on October 26th. This live, interactive online event will give existing shareholders and the investment community the opportunity...

Oct 11, 2022 08:00 am ET

HealthTab™ Roll Out on Track and Operations Cashflow Positive

AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “AVCR”) is pleased to provide this corporate update on the Company’s execution expanding its powerful chronic-disease screening and reporting platform, HealthTab. On August 8th, the Company...

Sep 20, 2022 08:00 am ET

Avricore Health Announces CEO Update Call on Sept. 22, 2022

AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) is excited to offer a live discussion on the Company’s current activities and forward outlook as it executes a significant national scale-up of its pharmacy-based point-of-care platform,...

Sep 19, 2022 08:30 am ET

Avricore Health Supports the Globe and Mail’s Health Innovation Event

AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) was honoured to join the Globe and Mail’s recent Health Care Innovation event, featuring leaders from various corners of the sector, including Company CEO, Hector Bremner. “With about 40%...

Aug 29, 2022 08:30 am ET

Avricore Health Reports Second-Quarter 2022 Results

AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) is pleased to provide this corporate update on the Company’s Q2 results. “We have now begun a new era for Healthtab™ and the Company as we expand Shoppers Drug Mart significantly over the...

Aug 10, 2022 09:18 pm ET

Avricore Grants Options

AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) is pleased to announce that the Company’s board of directors has approved the granting of stock options (the “Options”) exercisable for a total of 2,725,000 common shares to its directors,...

Aug 08, 2022 08:30 am ET

Healthtab™ Expands With Shoppers Drug Mart®

AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) is pleased to announce that the Company is significantly expanding the number of Shoppers Drug Mart pharmacies offering its HealthTab point-of-care testing platform under a renewed Master...

Jun 02, 2022 07:30 am ET

Avricore Health Executing Growth Strategy - Summer 2022 Corporate Update

AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) is pleased to provide this corporate update on the Company’s activities and progress in the first five months of 2022, as well as an outlook on the Company’s objectives and expectations...

Jan 25, 2022 08:00 am ET

Avricore Health CEO and Special Guests Join Radius Research for Investor Update

AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) is excited to be joined by Shoppers Drug Mart Pharmacist and Associate Owner, Mohamad Adel Elsabakhawi and Abbott Rapid Diagnostics' General Manager Daniel St. Pierre and National Sales...

Dec 09, 2021 01:51 pm ET

Avricore Health CEO Hosts Investor Call December 15th

AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) will host a year end update and look ahead discussion by the Company’s CEO and key team members. “We’ve had our best year yet, despite many external factors that created headwinds, and...

Nov 23, 2021 07:30 am ET

HealthTab™ to Offer Abbott’s i-STAT Alinity™, Expanding Chronic Disease Testing to Select Community Pharmacies in Canada

Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) is pleased to announce the signing of a non-exclusive, pilot supplier distribution agreement in Canada between HealthTab™ Inc., a wholly owned subsidiary, and...

Oct 26, 2021 08:00 am ET

HealthTab™ Expands to British Columbia in Select Shoppers Drug Mart® Locations

AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) announces that it has expanded patient testing with the HealthTab™ platform in select Shoppers Drug Mart® pharmacies in British Columbia, bringing its diabetes screening program to Western...

Oct 14, 2021 08:30 am ET

Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) on Mission to Make Health Info Accessible to All

NetworkNewsAudio – Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) announces the availability of a broadcast titled, “Real-World Data, Point-of-Care Testing Reshaping Healthcare, Detecting Diseases Sooner.” To hear the AudioPressRelease,...

Oct 13, 2021 08:30 am ET

Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) Wheelhouse at Center of Nascent Industry

via InvestorWire — Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one of 50+ trusted brands in the InvestorBrandNetwork (“IBN”), a multifaceted financial news...

Oct 05, 2021 08:17 am ET

IBN (InvestorBrandNetwork) Announces Latest Episode of The Bell2Bell Podcast Featuring Hector Bremner, CEO of Avricore Health Inc.

via InvestorWire -- IBN (InvestorBrandNetwork), a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of the latest episode of The Bell2Bell Podcast as part...

Sep 13, 2021 08:00 am ET

Avricore Health Engages Oak Hill Financial to Provide Investor Relations and Advisory Services

AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) announces that it has appointed Oak Hill Financial Services Inc. (“Oak Hill”) to provide the Company with investor relations and advisory services. Oak Hill is a Toronto-based financial...

Aug 10, 2021 05:00 am ET

HealthTab™ Systems Deployed in Select Shoppers Drug Mart® Locations, Patient Testing Begins

AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) announces that patient testing has begun on the HealthTab™ platform in select Shoppers Drug Mart® pharmacies. The participating Shoppers Drug Mart® pharmacies have now received their...

Jul 28, 2021 09:55 am ET

Avricore Health Partners with Ellerca Health Inc to Offer Joint Diabetes Screening and Management Support

Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) is pleased to announce it has signed a partnership agreement with Ellerca Health Corp to utilize their respective technologies and services to offer the most robust...

Jul 26, 2021 08:00 am ET

HealthTab™ Adds ID Now™ Molecular Test Device to Abbott Distribution Agreement, Now Offers First Real-time Reporting of SARS-CoV-2, Flu, Strep and RSV System in Pharmacy

Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) is pleased to announce the signing of the first amendment to its supplier distribution agreement between HealthTab™ Inc., a wholly owned subsidiary, and Abbott, the...

Jul 19, 2021 09:33 am ET

Beta-Testing of New HealthTab™ System in First Shoppers Drug Mart® Pharmacy Performs Well, Shows Strong Patient Demand

AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) announces that patient testing has begun on the first deployment of the new HealthTab™-integrated Afinion 2™ analyzers in the initial Shoppers Drug Mart® pharmacy location as part of its...

Jun 30, 2021 07:00 am ET

Avricore Health CEO Hosts Investor Call July 6th

AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) is hosting the first of a regular series of investor calls hosted by the Company’s CEO and key team members to provide progress updates and take questions. “We have many enthusiastic...

Jun 29, 2021 07:00 am ET

First HealthTab™ Testing Success in Shoppers Drug Mart® Pilot Rollout

AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) announces it has successfully launched HealthTab™ in the first of 11 Shoppers Drug Mart pilot locations. The rollout is part of its recently announced Master Agreement and Statement of...

Jun 22, 2021 08:35 am ET

Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th

Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) based in Vancouver, Canada focused on networked point-of-care testing in pharmacies technology HealthTab™ today announced that CEO, Hector Bremner will present live...

Jun 09, 2021 08:00 am ET

Avricore Health Corporate Update Summer 2021

AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) is pleased to provide this corporate update on the Company’s successes in 2021, which have included securing significant financing and key commercial agreements, putting it on track for...

Jun 03, 2021 09:30 am ET

Avricore Health Signs Master Agreement to Pilot HealthTab™ Platform for Diabetes Management in Select Shoppers Drug Mart® Pharmacies

Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) is pleased to announce patients will soon have access to its innovative point-of-care blood screening and health-data management platform, HealthTab™, at select...

May 31, 2021 08:00 am ET

Avricore Health’s HealthTab™ Signs Distribution Agreement to Expand Pharmacy Network and Test Offering

Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) is pleased to announce the signing of a supplier distribution agreement between HealthTab™ Inc., a wholly owned subsidiary, and Abbott, the global healthcare company...

Mar 26, 2021 08:00 am ET

Avricore Health Announces Return of HealthTab™ Founder to Communications and Marketing Role

AVRICORE HEALTH INC. (TSXV: AVCR, OTC: AVCRF) (the "Company" or “AVCR”) is pleased to announce the return of HealthTab Co-Founder, Will Seccombe, in the role of Communications Advisor. Will brings over 18 years of experience in the field with some...

Mar 18, 2021 08:30 am ET

Avricore Health Finalizes Agreement With Avrok Laboratories to Offer Real-Time Covid-19 Screening

Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) is pleased to announce it has signed the Definitive Agreement with Avrok Laboratories (Avrok), a CLIA certified laboratory in California, to offer COVID-19...

Feb 16, 2021 08:00 am ET

Avricore Health Partners With Avrok Laboratories to Offer Real-Time COVID-19 Screening for Travellers

Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) is pleased to announce it has signed a Letter of Intent with Avrok Laboratories (Avrok), a CLIA certified laboratory in California, to offer COVID-19 screening to...

Feb 12, 2021 08:30 am ET

Avricore Health Completes $1.54 Million Financing and Grants Options

AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “Avricore”) announces it has closed its non-brokered private placement announced on February 3rd for gross proceeds of $1,540,000. The Company will issue 7,000,000 units at $0.22 per unit and will...

Feb 09, 2021 08:00 am ET

Whole Health Pharmacy Partners to Launch Avricore’s HealthTab™

Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) is pleased to announce it will be placing its real-time reporting HealthTab™ systems in Whole Health Pharmacy Partner locations. “We’ve been excited by the...

Feb 03, 2021 08:05 pm ET

Avricore Health Announces $1.54 Million Financing

AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “Avricore”) announces a non-brokered private placement of up to 7,000,000 units ("Units") at a price of $0.22 per unit for gross proceeds of $1,540,000. (the "Private Placement"). The proceeds...

Jan 26, 2021 08:00 am ET

Avricore Health Completes $1.5 Million Financing

AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “Avricore”) announces it has closed the final tranche of its non-brokered private placement for gross proceeds of $874,000 to complete its $1.5 million financing. The Company will issue 8,740,000...

Dec 14, 2020 04:45 am ET

Avricore Health Successfully Intergrates ID Now™ Rapid PCR Test Device, Offering Real-Time Covid-19 Reporting Direct From Instrument for First Time.

AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) is pleased to announce that its engineering team, led by Chief Technology Officer, Rodger Seccombe, have successfully integrated its real-time reporting platform HealthTab™ and the ID...

Dec 10, 2020 07:45 am ET

Avricore Health Announces Board of Directors Change, New Advisor

AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) announces changes to its board of directors today as the Company continues to make significant progress towards its objective of bringing comprehensive point-of-care testing and reporting...

Dec 03, 2020 07:15 am ET

Avricore’s HealthTab Expands North With Oak Medical Arts

Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) is pleased to announce it will be placing its real-time reporting HealthTab™ systems in Oak Medical Art’s community pharmacy locations, bringing advanced point of...

Nov 24, 2020 08:37 pm ET

CORRECTION – Avricore Health Closes $626,000 First Tranche of Financing

In a release issued under the same headline on Friday, November 13, by Avricore Health Inc. (TSXV: AVCR), the units issued figure was meant to be 6,260,000, not 6,360,000. The corrected release follows: AVRICORE HEALTH INC. (TSXV: AVCR) (the...

Nov 23, 2020 07:55 am ET

Avricore Health’s HealthTab™ Endorsed by Ontario Pharmacists Association for Real-Time COVID-19 Data Reporting in Community Pharmacies

Avricore Health Inc. (TSXV: AVCR) and the Ontario Pharmacists Association (OPA) are pleased to announce the expansion of their partnership agreement to endorse and promote the Company’s HealthTab™ as a real-time data reporting platform for COVID-19...

Nov 13, 2020 08:30 am ET

Avricore Health Closes $626,000 First Tranche of Financing

AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “Avricore”) announces it has closed the first tranche of its non-brokered private placement for gross proceeds of $626,000. The Company will issue 6,360,000 units at $0.10 per unit and will pay...

Oct 14, 2020 08:00 am ET

Avricore Health Announces $1.5 Million Financing

AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “Avricore”) announces a non-brokered private placement of up to 15,000,000 units ("Units") at a price of $0.10 per unit for gross proceeds of $1,500,000. (the "Private Placement"). The proceeds...

Oct 08, 2020 08:00 am ET

Avricore Health’s HealthTab™ Achieves Critical Milestones in Connecting New Testing Device

Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) ("Avricore" or the "Company") has achieved significant milestones in completing due diligence, technical reviews and initial connectivity between its real-time data reporting platform, HealthTab™ and a...

Sep 22, 2020 08:00 am ET

HealthTab™ Integrating New Device to Add HbA1c Blood Glucose Testing to Its Real-Time Data Reporting System

Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) ("Avricore" or the "Company") is pleased to announce the signing of a Letter of Intent (LOI) with a prominent, publicly traded healthcare technology company and drug maker which serves as the foundation...

Sep 10, 2020 11:43 pm ET

Avricore Health Amends Options

Avricore Health Inc. (TSXV: AVCR) (the "Company" or “Avricore”) announces that its Board of Directors and Shareholders have approved (subject to TSXV approval) the re-pricing of a total of 2,091,072 options to purchase common shares ("Options") to...

Sep 09, 2020 08:30 am ET

Avricore Health’s HealthTab™ to Enable Real Time Reporting of COVID-19 Results in Pharmacy

Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) ("Avricore" or the "Company") a leader in pharmacy-based point-of-care testing solutions, plans to offer its HealthTab™ system as a stand-alone service to improve COVID19 case reporting. “Timely and...

Jul 10, 2020 04:39 pm ET

Avricore Health Completes Shares for Debt Transaction

AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “AVCR”) is pleased to announce that it has settled and extinguished $136,949 of the Company’s outstanding debt through the issuance of 5,477,965 common shares (“Shares”) of the Company at a deemed...

Jul 06, 2020 01:56 pm ET

Avricore Health Amends Shares for Debt News Release

AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) wishes to amend its news release dated July 2, 2020 in which it announced a shares for debt transaction. Aggregate shares has been amended from 5,077,965 to 5,477,965 shares....

Jul 02, 2020 06:52 pm ET

Avricore Health Announces Shares for Debt Transaction

AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) is pleased to announce that it has entered into shares for debt agreements, to satisfy an aggregate of $126,949 of the Company’s outstanding debts. The Company has reached agreements with...

Jun 29, 2020 09:44 am ET

Avricore Health Corporate Update: Diversifies Revenues During COVID-19

Avricore Health (TSXV: AVCR), like so many other business, has faced both challenges and opportunities over the past several weeks. Thankfully, we’ve not had any team members sick, however, one close partner did spend time in hospital, bringing...

Mar 06, 2020 02:55 pm ET

Avricore Health Announces $1 Million Secured Loan

Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) ("Avricore Health" or the "Company") a leader in point-of-care testing and health data generation, announced today that subject to regulatory approval it has entered into a loan agreement with Canam...

Jan 21, 2020 07:30 am ET

New Pharmacy Partnership Optimizes Patient Care Through Data Driven Solutions

Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) and the Ontario Pharmacists Association (OPA) are pleased to announce the finalized partnership agreement to promote HealthTab™, a point-of-care blood screening tool...

Nov 28, 2019 08:00 am ET

Avricore’s HealthTab™ Coming to 11 New Community Pharmacy Locations

Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) is pleased to announce it will be placing HealthTab™ systems in 11 new community pharmacy locations more than doubling the number of HealthTab™ systems located in...

Nov 18, 2019 08:30 am ET

Ontario Pharmacists and Avricore Health Partner to Expand HealthTab™ in Community Pharmacies and Enhance Patient Care

Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) and the Ontario Pharmacists Association (OPA) are pleased to announce a Memorandum of Understanding (MOU) to offer in partnership the Company’s HealthTab™...

Nov 01, 2019 08:18 am ET

BELGRAVIA Provides Legal Update

BELGRAVIA CAPITAL INTERNATIONAL INC. (CSE:BLGV) (OTCQB:BLGVF) (“Belgravia” or the “Company”) reports on the status of its legal actions relating to protecting and enforcing the Company’s interests in its investments. Belgravia has taken legal...

Oct 15, 2019 03:07 pm ET

Avricore Health Appoints CEO, President and Advisors

Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) Board of Directors announces the appointment of Hector Bremner as Chief Executive Officer and Bob Rai as President effective immediately. Bremner previously held the...

Sep 17, 2019 08:30 am ET

Avricore Health and Clinart MENA Announce Interim Agreement for HealthTab™ + RASTR Network Middle East Expansion

Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) ("Avricore Health" or the "Company") is pleased to announce that it has signed a first stage agreement in the form of a Letter of Intent (LOI) with Dubai based clinical research organization, Clinart,...

Aug 20, 2019 07:00 am ET

Avricore Health Corporate Update and Private Placement Extension

Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) ("Avricore Health" or the "Company") is pleased to provide an update on the significant progress the company has made over the summer to complete its transition into the world leader in providing...

Aug 14, 2019 12:00 pm ET

Avricore Health Closes $340K First Tranche of Placement

Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) ("Avricore Health" or the "Company") announces that it has closed the first tranche of its previously announced non-brokered private placement by issuing 6,852,400 units (the "Units") at a price of...

Aug 06, 2019 08:00 am ET

Avricore Health Welcomes Kiki Smith as Chief Financial Officer

Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) ("Avricore Health" or the "Company") announces the appointment of Ms. Kiki Smith, CPA, CGA to the role of Chief Financial Officer, where she will oversee the financial team operations, investor...

Jul 19, 2019 07:47 pm ET

Avricore Health Extends Closing of Placement

Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) ("Avricore Health" or the "Company") announces that, further to its news releases dated June 5, 2019 and July 11, 2019, the TSX Venture Exchange has granted the Company a 30 day extension from the date...

Jul 11, 2019 06:01 pm ET

Correction - Avricore Health Announces Amendment to Placement Terms

Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) ("Avricore Health" or the "Company") announces that it has amended the terms of its non-brokered private placement offering (the "Private Placement") of units of the Company (the "Units") previously...

Jul 11, 2019 08:00 am ET

Avricore Health Announces Amendment to Placement Terms

Jun 18, 2019 08:00 am ET

Avricore Health announces new appointments

Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) announces today additions and changes to its board and executive team as the Company continues to align itself for further growth in the year ahead. Sherif Guorgui...

Jun 05, 2019 08:00 am ET

Avricore Health announces private placement

Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) is pleased to announce a non-brokered private placement of up to 21,428,571 units of the Company (the “Units”) at a price of $0.07 per Unit for aggregate gross...

Jun 04, 2019 10:24 am ET

Avricore Health Announces Lifting of Management Cease Trade Order

Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) ("Avricore Health" or the "Company") reports that the Management Cease Trade Order granted by the British Columbia Security Commission on May 2, 2019 was lifted effective June 3, 2019 following the...

May 23, 2019 08:00 am ET

Avricore Health Inc. Installs New CFO and Corporate Secretary

Avricore Health Inc. (TSXV: AVCR) (OTCBB: AVCR) (“Avricore Health”) is expanding its capacity to meet its objectives by adding Kevin Strong as Chief Financial Officer and Deena Siblock as Corporate Secretary, effective today. “We are poised...

May 16, 2019 05:28 pm ET

Avricore Health Provides Update on Status of Management Cease Trade Order

Avricore Health Inc. (TSXV: AVCR) (“Avricore Health” or the “Company”) is providing this update on the status of a management cease trade order granted on May 2, 2019 (the "MCTO") by the British Columbia Securities Commission under National Policy...

May 07, 2019 08:00 am ET

Avricore Health and Molecular You Announce Launch of myCannabisPGx Genetic Test for Safe Medical Cannabis Use

Avricore Health Inc. (TSXV: AVCR) (“Avricore Health”) has signed a distribution agreement with Molecular You Corporation (“Molecular You”) to provide its newly developed genetic medication response test myCannabisPGxTM, which is designed to ensure...

May 02, 2019 05:22 pm ET

Avricore Health Announces Late Filing of Annual Financial Statements and Management Cease Trade Order

Avricore Health Inc. (TSXV: AVCR) (“Avricore Health” or the “Company”) announced today that as a result of delays in completion of its audit, the Company did not file its financial statements and accompanying management's discussion and analysis...

Apr 26, 2019 04:01 pm ET

Avricore Health Provides Corporate Update

Avricore Health Inc. (TSXV: AVCR) (“Avricore”) announced today the resignation of Ms. Leanne Ratzlaff as Corporate Secretary effective immediately. Due to the growth in Avricore's business and its near-term corporate objectives, it requires a...

Apr 03, 2019 09:00 am ET

Avricore Health Inc. Launches New Website

Avricore Health Inc. (TSXV: AVCR) (“Avricore Health”) As part of Avricore Health’s commitment to providing the most accurate and best Point-of-Care-Technologies (POCT) to support new clinical services and revenue streams for pharmacist across...

Mar 19, 2019 08:30 am ET

Avricore Health Inc. Advisory Board Welcomes Mark Zhou

Avricore Health Inc. (TSXV: AVCR) (“Avricore Health”) is very pleased to announce that Mark Zhou will join the company’s Advisory Board and support strategic operations and government affairs. As the Western Canadian Pharmacy Services Manager...

Feb 06, 2019 07:02 am ET

Avricore Health Provides Update and Outlook for 2019

Vancouver / TheNewswire / February 6, 2019 – Avricore Health Inc. (TSX-V: AVCR) (OTCQB: AVCRF) (“Avricore Health” or the “Company”)

Jan 30, 2019 07:01 am ET

Avricore Health Inc. Advisory Board Welcomes Hector Bremner

Communications professional and former advisor to BC Deputy Premier and Vancouver City Councillor will support Strategic and Government Affairs

Jan 29, 2019 07:01 am ET

Avricore Health Inc. Advisory Board Welcomes Ray Chepesiuk

Dec 19, 2018 08:30 am ET

Avricore Health Signs Letter of Intent with Molecular You to Further Enhance the HealthTab Platform with Tests Designed to Ensure Safe Cannabis Use

Avricore Health Inc. (TSXV: AVCR) (“Avricore Health”) is pleased to announce that it has signed a Letter of Intent (LOI) with Molecular You Corporation (“Molecular You”) to distribute Molecular You’s pharmacogenomic tests designed to ensure safe...

Nov 27, 2018 08:00 am ET

Avricore Health Signs Letter of Intent to Partner with FoodRocket to Enhance the HealthTab Platform

Avricore Health Inc. (TSXV: AVCR) (“Avricore Health”) is pleased to announce that it has signed a letter of intent to review opportunities to collaborate with FoodRocket to integrate FoodRocket’s precision health offerings and genomics with the...

Ad blocking detected

Avricore Health Inc. (V:AVCR)

Business Focus: Pharmaceuticals (NEC)